AAAAAA

   
Results: 1-22 |
Results: 22

Authors: STRADER CD HWA JJ VANHEEK M PARKER EM
Citation: Cd. Strader et al., NOVEL MOLECULAR TARGETS FOR THE TREATMENT OF OBESITY, Drug discovery today, 3(6), 1998, pp. 250-256

Authors: WANG S PARKER EM
Citation: S. Wang et Em. Parker, GALANIN RECEPTOR SUBTYPES AS POTENTIAL THERAPEUTIC TARGETS, Expert opinion on therapeutic patents, 8(10), 1998, pp. 1225-1235

Authors: FREEDMAN SD KATZ MH PARKER EM LAPOSATA M URMAN MY ALVAREZ JG
Citation: Sd. Freedman et al., CYSTIC-FIBROSIS MAY BE EXPLAINED BY A PRIMARY DEFECT IN FATTY-ACID METABOLISM, Gastroenterology, 114(4), 1998, pp. 1864-1864

Authors: FREEDMAN SD PARKER EM KATZ MH
Citation: Sd. Freedman et al., ENDOCYTOSIS AT THE APICAL PLASMA-MEMBRANE OF THE PANCREATIC ACINAR CELL IS REGULATED BY A COMPLEX OF GP2 AND SRC KINASES, Gastroenterology, 114(4), 1998, pp. 1865-1865

Authors: FREEDMAN SD BHASKAR KR LEWANDROWSKI KB BRUGGE W WARSHAW AL KATZ MH PARKER EM WAXMAN I
Citation: Sd. Freedman et al., A DIAGNOSTIC MARKER FOR CYSTIC LESIONS OF THE PANCREAS, Gastroenterology, 114(4), 1998, pp. 2452-2452

Authors: PARKER EM BABIJ CK BALASUBRAMANIAM A BURRIER RE GUZZI M HAMUD F MUKHOPADHYAY G RUDINSKI MS TAO Z TICE M XIA L MULLINS DE SALISBURY BG
Citation: Em. Parker et al., GR231118 (1229U91) AND OTHER ANALOGS OF THE C-TERMINUS OF NEUROPEPTIDE-Y ARE POTENT NEUROPEPTIDE-Y Y-1 RECEPTOR ANTAGONISTS AND NEUROPEPTIDE-Y Y-4 RECEPTOR AGONISTS, European journal of pharmacology, 349(1), 1998, pp. 97-105

Authors: STRADER CD MACINTYRE DE CANDELORE MR PARKER EM
Citation: Cd. Strader et al., MOLECULAR APPROACHES TO THE DISCOVERY OF NEW TREATMENTS FOR OBESITY, CURRENT OPINION IN CHEMICAL BIOLOGY, 1(2), 1997, pp. 204-209

Authors: WANG SK HE CG MAGUIRE MT CLEMMONS AL BURRIER RE GUZZI MF STRADER CD PARKER EM BAYNE ML
Citation: Sk. Wang et al., GENOMIC ORGANIZATION AND FUNCTIONAL-CHARACTERIZATION OF THE MOUSE GALR1 GALANIN RECEPTOR, FEBS letters, 411(2-3), 1997, pp. 225-230

Authors: CLAWGES HM DEPREE KM PARKER EM GRABER SG
Citation: Hm. Clawges et al., HUMAN 5-HT1 RECEPTOR SUBTYPES EXHIBIT DISTINCT G-PROTEIN COUPLING BEHAVIORS IN MEMBRANES FROM SF9 CELLS, Biochemistry, 36(42), 1997, pp. 12930-12938

Authors: GLENNON RA DUKAT M WESTKAEMPER RB ISMAIEL AM IZZARELLI DG PARKER EM
Citation: Ra. Glennon et al., THE BINDING OF PROPRANOLOL AT 5-HYDROXYTRYPTAMINE(1D-BETA) T355N MUTANT RECEPTORS MAY INVOLVE FORMATION OF 2 HYDROGEN-BONDS TO ASPARAGINE, Molecular pharmacology, 49(1), 1996, pp. 198-206

Authors: PARKER EM IZZARELLI DG LEWISHIGGINS L PALMER D SHAPIRO RA
Citation: Em. Parker et al., 2 AMINO-ACID DIFFERENCES IN THE 6TH TRANSMEMBRANE DOMAIN ARE PARTIALLY RESPONSIBLE FOR THE PHARMACOLOGICAL DIFFERENCES BETWEEN THE 5-HT1D-BETA AND 5-HT1E 5-HYDROXYTRYPTAMINE RECEPTORS, Journal of neurochemistry, 67(5), 1996, pp. 2096-2103

Authors: SARBIN NS GYLYS JA IBEN LG MAHLE CD IZZARELLI DG PARKER EM NOONAN JW WILLIAMS AD SMITH DW HAMEL E YOCCA FD
Citation: Ns. Sarbin et al., THE RECEPTOR-BINDING AND VASCULAR IN-VITRO PHARMACOLOGICAL PROFILE OFBMS-180048, A NOVEL ANTIMIGRAINE AGENT, The FASEB journal, 9(3), 1995, pp. 347-347

Authors: FATHI Z IBEN LG PARKER EM
Citation: Z. Fathi et al., CLONING, EXPRESSION, AND TISSUE DISTRIBUTION OF A 5TH MELANOCORTIN RECEPTOR SUBTYPE, Neurochemical research, 20(1), 1995, pp. 107-113

Authors: PARKER EM HUTCHISON M BLUMER JL
Citation: Em. Parker et al., THE PHARMACOKINETICS OF MEROPENEM IN INFANTS AND CHILDREN - A POPULATION ANALYSIS, Journal of antimicrobial chemotherapy, 36, 1995, pp. 63-71

Authors: PARKER EM IZZARELLI DG NOWAK HP MAHLE CD IBEN LG WANG JC GOLDSTEIN ME
Citation: Em. Parker et al., CLONING AND CHARACTERIZATION OF THE RAT GALR1 GALANIN RECEPTOR FROM RIN14B INSULINOMA CELLS, Molecular brain research, 34(2), 1995, pp. 179-189

Authors: BLUM IH KOSKINEN PS TENNANT N PARKER EM STRAUB M CURRY C
Citation: Ih. Blum et al., USING AUDIOTAPED BOOKS TO EXTEND CLASSROOM LITERACY INSTRUCTION INTO THE HOMES OF 2ND-LANGUAGE LEARNERS, Journal of reading behavior, 27(4), 1995, pp. 535-563

Authors: PARKER EM SWIGART P NUNNALLY MH PERKINS JP ROSS EM
Citation: Em. Parker et al., CARBOXYL-TERMINAL DOMAINS IN THE AVIAN BETA(1)-ADRENERGIC RECEPTOR THAT REGULATE AGONIST-PROMOTED ENDOCYTOSIS (VOL 270, PG 6482, 1995), The Journal of biological chemistry, 270(17), 1995, pp. 10358-10358

Authors: PARKER EM SWIGART P NUNNALLY MH PERKINS JP ROSS EM
Citation: Em. Parker et al., CARBOXYL-TERMINAL DOMAINS IN THE AVIAN BETA(1)-ADRENERGIC RECEPTOR THAT REGULATE AGONIST-PROMOTED ENDOCYTOSIS, The Journal of biological chemistry, 270(12), 1995, pp. 6482-6487

Authors: NEBIGIL CG GARNOVSKAYA MN CASANAS SJ MULHERON JG PARKER EM GETTYS TW RAYMOND JR
Citation: Cg. Nebigil et al., AGONIST-INDUCED DESENSITIZATION AND PHOSPHORYLATION OF HUMAN 5-HT1A RECEPTOR EXPRESSED IN SF9 INSECT CELLS, Biochemistry, 34(37), 1995, pp. 11954-11962

Authors: PARKER EM GRISEL DA IBEN LG NOWAK HP MAHLE CD YOCCA FD GAUGHAN GT
Citation: Em. Parker et al., CHARACTERIZATION OF HUMAN 5-HT1 RECEPTORS EXPRESSED IN SF9 INSECT CELLS, European journal of pharmacology. Molecular pharmacology section, 268(1), 1994, pp. 43-53

Authors: PITSIU M PARKER EM AARONS L ROWLAND M
Citation: M. Pitsiu et al., POPULATION PHARMACOKINETICS AND PHARMACODYNAMICS OF WARFARIN IN HEALTHY-YOUNG ADULTS, European journal of pharmaceutical sciences, 1(3), 1993, pp. 151-157

Authors: WISDEN W PARKER EM MAHLE CD GRISEL DA NOWAK HP YOCCA FD FELDER CC SEEBURG PH VOIGT MM
Citation: W. Wisden et al., CLONING AND CHARACTERIZATION OF THE RAT 5-HT(5B)RECEPTOR - EVIDENCE THAT THE 5-HT(5B)RECEPTOR COUPLES TO A G-PROTEIN IN MAMMALIAN-CELL MEMBRANES, FEBS letters, 333(1-2), 1993, pp. 25-31
Risultati: 1-22 |